TorPharm omeprazole approval
FDA approves Apotex subsidiary's ANDA for omeprazole (AstraZeneca's Prilosec) Oct. 6. Apotex has not announced a launch date, but it is expected by the trade that the generic will be available in mid-November. Apotex would be the fourth generic on the market, following Schwarz, Mylan and Lek (1"The Pink Sheet" Aug. 25, 2003, p. 10)...
You may also be interested in...
Novartis' Lek generic division is following Mylan with an "at risk" launch of generic omeprazole
France plans to begin issuing manufacturing quality certificates so firms can import ordinary cosmetics into China without animal testing under a 2020 draft regulation. The Personal Care Products Council is working to find a comparable solution for US manufacturers.
The calcineurin inhibitor, only the second drug to be approved by the US FDA for lupus nephritis, will be competing against GlaxoSmithKline’s Benlysta.